Evidence map›Paper›PMID 24248382›Full record

Trial reportProceedings of the National Academy of Sciences of the United States of America2013

RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia.

Tao Zu, Yuanjing Liu, Monica Bañez-Coronel, Tammy Reid, Olga Pletnikova, Jada Lewis, Timothy M Miller, Matthew B Harms, Annet E Falchook, S H Subramony and 4 more

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 535 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
535citing papers in PubMed, 1 pooled it
32.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

535 citing papers in PubMed, 1 synthesis or guideline pooled it, 776 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Quality control and signaling pathways at stalled ribosomes.Experimental & molecular medicine · 2026
    Review
  20. Article

475 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Tao ZuDepartment of Molecular Genetics and Microbiology, Department of Neurology, and Department of Neuroscience, Center for NeuroGenetics, Genetics Institute, College of Medicine, University of Florida, Gainesville, FL 32610.
Yuanjing Liu
Monica Bañez-Coronel
Tammy Reid
Olga Pletnikova
Jada Lewis
Timothy M Miller
Matthew B Harms
Annet E Falchook
S H Subramony
Lyle W Ostrow
Jeffrey D Rothstein
Juan C Troncoso
Laura P W Ranum
Laboratory of Molecular Genetics · PLCereal Disease Laboratory · USJohns Hopkins Medicine · USWashington University in St. Louis · USUniversity of Florida · US

Funding

'T V ASSESSMENT - MEMORY DISORDERED PATIENTS'P50AG005146 · NIA · JOHNS HOPKINS UNIVERSITY · PI HUGANIR, RICHARD L · 1985 to 2019
$37.6M
Temporal/spatial RNA Expression Effects in DM1 and DM2P01NS058901 · NINDS · UNIVERSITY OF MINNESOTA · PI RANUM, LAURA P.W · 2008 to 2017
$12.3M
MOLECULAR GENETIC CHARACTERIZATION OF SCA8R01NS040389 · NINDS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI RANUM, LAURA P.W · 2000 to 2010
$3.8M
ALS/FTD mutant C9orf72-induced genetic and nuclear pathology in iPS cell modelsR01NS085207 · NINDS · JOHNS HOPKINS UNIVERSITY · PI ROTHSTEIN, JEFFREY D, SATTLER, RITA · 2013 to 2017
$1.8M
NEXT-GENERATION SEQUENCING APPROACHES FOR NOVEL GENE DISCOVERY IN ALSK08NS075094 · NINDS · WASHINGTON UNIVERSITY · PI HARMS, MATTHEW · 2011 to 2015
$787k
NIA NIH HHS NIH P50AG05146NIA NIH HHS P50 AG005146NINDS NIH HHS K08 NS075094NINDS NIH HHS P01 NS058901NINDS NIH HHS R01 NS040389NINDS NIH HHS R01 NS085207
6 · The paper itself

Abstract

The finding that a GGGGCC (G4C2) hexanucleotide repeat expansion in the chromosome 9 ORF 72 (C9ORF72) gene is a common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) links ALS/FTD to a large group of unstable microsatellite diseases. Previously, we showed that microsatellite expansion mutations can be bidirectionally transcribed and that these mutations express unexpected proteins by a unique mechanism, repeat-associated non-ATG (RAN) translation. In this study, we show that C9ORF72 antisense transcripts are elevated in the brains of C9ORF72 expansion-positive [C9(+)] patients, and antisense GGCCCC (G2C4) repeat-expansion RNAs accumulate in nuclear foci in brain. Additionally, sense and antisense foci accumulate in blood and are potential biomarkers of the disease. Furthermore, we show that RAN translation occurs from both sense and antisense expansion transcripts, resulting in the expression of six RAN proteins (antisense: Pro-Arg, Pro-Ala, Gly-Pro; and sense: Gly-Ala, Gly-Arg, Gly-Pro). These proteins accumulate in cytoplasmic aggregates in affected brain regions, including the frontal and motor cortex, hippocampus, and spinal cord neurons, with some brain regions showing dramatic RAN protein accumulation and clustering. The finding that unique antisense G2C4 RNA foci and three unique antisense RAN proteins accumulate in patient tissues indicates that bidirectional transcription of expanded alleles is a fundamental pathologic feature of C9ORF72 ALS/FTD. Additionally, these findings suggest the need to test therapeutic strategies that target both sense and antisense RNAs and RAN proteins in C9ORF72 ALS/FTD, and to more broadly consider the role of antisense expression and RAN translation across microsatellite expansion diseases.

Indexed as

Amyotrophic Lateral SclerosisBrainC9orf72 ProteinCell NucleusFemaleFrontotemporal DementiaHEK293 CellsHumansMaleNerve Tissue ProteinsProteinsran GTP-Binding ProteinRepetitive Sequences, Nucleic AcidRNA, AntisenseC9orf72 ProteinC9orf72 protein, humanNerve Tissue ProteinsProteinsran GTP-Binding ProteinRAN protein, humanRNA, Antisenseclustered aggregatescytoplasmic inclusionsnoncoding RNA

Identifiers

PMID24248382
PMCPMC3870665
OpenAlexW2013488820

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.